Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer Study

BACKGROUND: We have previously reported that expression of the RNA- and DNA-binding protein RBM3 is associated with a good prognosis in breast cancer and ovarian cancer. In this study, the prognostic value of immunohistochemical RBM3 expression was assessed in incident cases of malignant melanoma fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonsson, Liv, Bergman, Julia, Nodin, Björn, Manjer, Jonas, Pontén, Fredrik, Uhlén, Mathias, Jirström, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156749/
https://www.ncbi.nlm.nih.gov/pubmed/21777469
http://dx.doi.org/10.1186/1479-5876-9-114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156749/
https://www.ncbi.nlm.nih.gov/pubmed/21777469
http://dx.doi.org/10.1186/1479-5876-9-114

Ejemplares similares